MedRx Co., Ltd (TYO:4586)
67.00
+1.00 (1.52%)
Aug 27, 2026, 3:30 PM JST
MedRx Market Cap
MedRx has a market cap or net worth of 3.98 billion as of August 27, 2026. Its market cap has decreased by -46.90% in one year.
Market Cap
3.98B
Enterprise Value
2.83B
Revenue
121.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
67.00
ChartMarket Cap Chart
Since February 13, 2013, MedRx's market cap has decreased from 11.76B to 3.98B, a decrease of -66.18%. That is a compound annual growth rate of -7.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 3.98B | -37.96% |
| Dec 30, 2025 | 6.41B | 65.15% |
| Dec 30, 2024 | 3.88B | -32.98% |
| Dec 29, 2023 | 5.79B | 117.37% |
| Dec 30, 2022 | 2.67B | -15.34% |
| Dec 30, 2021 | 3.15B | -20.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fuji Pharma | 48.16B |
| Daito Pharmaceutical | 39.52B |
| Mizuho Medy | 33.01B |
| Koa Shoji Holdings | 32.30B |
| Fuso Pharmaceutical Industries,Ltd. | 19.71B |
| Pharma Foods International | 18.09B |
| Taiko Pharmaceutical | 13.48B |
| Wakamoto Pharmaceutical | 10.82B |